|
Petmed Express, Inc. - Comparative Business Analysis Snapshot
Business Description
Petmed Express, Inc.. The Group's principal activity is to markets prescription and non-prescription pet medications, and other health products for dogs, cats and horses direct to the consumer. It offers an attractive alternative for obtaining pet medications in terms of convenience, price and speed of delivery. The Group's current product line contains approximately 750 skus. These products include a majority of the well-known brands of medication, such as Frontline Plus(R), K9 Advantix(R), Advantage(R), Heartgard Plus(R), Sentinel(R), Interceptor(R), Program(R), Revolution(R), Deramaxx(R) and Rimadyl(R).It markets products through national television, online and direct mail/print advertising campaigns, which aim to increase the recognition of the 1-800-PetMeds brand name, and PetMeds family of trademarks, increase traffic on its website at www.1800petmeds.com, acquire new customers and maximize repeat purchases.
Competitor Analysis
This analysis compares Petmed Express, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
